The Latest Breaking News from Quest Diagnostics

Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.97.

What are Value Stocks?

The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis.  Quest was awarded the contract following a competitive bid. The total contract value with all options is valued…

If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Treinta y siete estados ahora le permiten a los adultos consumir marihuana con fines médicos, recreativos o ambos. Pero, en la mayoría de esos estados, las personas pueden ser despedidas o se les puede negar un trabajo si consumen cannabis en su tiempo libre.

Thirty-seven states now allow adults to use marijuana medically, recreationally or both. But in most of those states, people can be fired or denied a job for using cannabis in their free time.

Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:

Quest Diagnostics will pay $90,000 to settle a religious discrimination lawsuit brought by the U.S. Equal Employment Opportunity Commission on behalf of a phlebotomist working in Rockwall, Texas.

Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected